Advanced Elementary...
Health Care: Drugs
Novo Nordisk A/S (NVO: NYSE)
$161.87 0.17 | 0.11%
06/18/13 - 04:02 PM ET
Company Income Statement
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Sales | 13.83B | 11.58B | 10.84B | 9.83B |
| Cost of Sales | 1.91B | 2.20B | 1.64B | 1.52B |
| Gross Operating Profit | 11.92B | 9.38B | 9.20B | 8.32B |
| Selling, General, and Administrative Expenses | 4.41B | 3.88B | 3.79B | 3.50B |
| Research & Development | 1.93B | 1.68B | 1.71B | 1.51B |
| Operating Income before D & A (EBITDA) | 5.58B | 3.82B | 3.69B | 3.30B |
| Depreciation & Amortization | 477.31M | 0.00 | 440.09M | 491.19M |
| Interest Income | 22.15M | 89.71M | 68.14M | 72.21M |
| Other Income - Net | 236.08M | -698.13K | 425.28M | 120.73M |
| Special Income / Charges | -118.04M | 86.22M | -117.20M | -65.66M |
| Total Income Before Interest Expenses (EBIT) | 5.25B | 3.99B | 3.63B | 2.94B |
| Interest Expense | 316.90M | 167.38M | 366.95M | 243.57M |
| Pre-Tax Income | 4.93B | 3.83B | 3.26B | 2.69B |
| Income Taxes | 1.13B | 842.64M | 692.69M | 620.01M |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing Operations | 3.80B | 2.98B | 2.57B | 2.07B |
| Net Income From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Total Operations | 3.80B | 2.98B | 2.57B | 2.07B |
| Extraordinary Income/Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Cum. Effect of Acct. Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Tax Loss Carryforward | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Net Income | 3.80B | 2.98B | 2.57B | 2.07B |
| Normalized Income (Net Income From Continuing Operations, Ex. Special Income / Charge) |
3.92B | 2.90B | 2.69B | 2.14B |
| Preferred Dividends | ||||
|---|---|---|---|---|
| Net Income Available To Common | 3.80B | 2.98B | 2.57B | 2.07B |
| Basic EPS from Continuing Ops. | 6.93 | 5.28 | 4.43 | 3.46 |
| Basic EPS from Discontinued Ops. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Total Operations | 6.93 | 5.28 | 4.43 | 3.46 |
| Basic EPS from Extraordinary Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Tax Loss Carryf'd. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Other Gains (Losses) | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS, Total | 6.93 | 5.28 | 4.43 | 3.46 |
| Basic Normalized Net Income/Share | 7.14 | 5.13 | 4.63 | 3.57 |
| EPS fr Continuing Ops. | 6.89 | 5.23 | 4.39 | 3.43 |
| EPS fr Discontinued Ops | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Total Ops. | 6.89 | 5.23 | 4.39 | 3.43 |
| EPS fr Extraord. Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Tax Loss Carfd. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Other Gains (L) | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS, Total | 6.89 | 5.23 | 4.39 | 3.43 |
| Diluted Normalized Net Inc/Shr (Net Income From Continuing Operations, Ex. Special Income / Charge) |
7.10 | 5.08 | 4.59 | 3.54 |
| Dividends Paid per Share | 1.83 | 1.36 | 0.98 | 0.78 |
Portfolios with NVO
- Portfolio NameUser Type
- ProRenaissance Technologies
- UserMY FAVORITE STOCKS
- ContributorHighest-Yielding Drug Stocks
- ProTom Gayner - Markel Gayner ...
- UserD and B
- Contributor5 Blue-Chip Stocks to Buy
- UserPicks for 2011 (navalier)
- Userkimsh Rate Pension
- UserBesh
- UserAndras Alliance
Latest NVO Headlines from TheStreet
- 3 Stocks Pushing The Drugs Industry Higher 04.15.13 | 01:04 pm
- 3 Stocks Improving Performance Of The Health Care Sector 04.03.13 | 01:04 pm
- 4 Stocks Dragging The Drugs Industry Downward 03.27.13 | 01:03 pm
- 4 Stocks Going Ex-Dividend Tomorrow: PNY, CIB, NVO, SWY 03.20.13 | 10:03 am
- Novo Nordisk A/S Stock To Go Ex-dividend Tomorrow (NVO) 03.20.13 | 09:03 am
- Generic Drugmaker Mylan Is A Smart Healthcare Play 03.19.13 | 11:03 pm
- Cramer's 6 Stocks in 60 Seconds: NVO HON UTX BCC KORS CY (Update 1) 03.18.13 | 05:03 pm
- 4 Stocks Pushing The Health Care Sector Higher 03.15.13 | 01:03 pm
- Novo Nordisk A/S (NVO): Today's Featured Drugs Laggard 03.06.13 | 05:03 pm
- 5 Stocks Pushing The Health Care Sector Lower 03.06.13 | 12:03 pm
Press Releases for NVO
- Sixty-One Per Cent Of Women Say Their Sex Lives Are Suffering Due To A Condition Of Menopause - PR Newswire 05.06.13 | 05:05 am
- Novo Nordisk Unveils New U.S. Headquarters - PR Newswire 04.19.13 | 12:04 pm
- Novo Nordisk Celebrates 90 Years Of Diabetes Innovation - PR Newswire 02.19.13 | 07:02 am
- Novo Nordisk Promotes Four Members Of U.S. Leadership Team To Senior Vice President - PR Newswire 01.31.13 | 08:01 am
- Global Survey Reveals More Than A Quarter Of Canadians With Type 2 Diabetes Do Not Take Insulin As Prescribed And One Third Are Experiencing Events Of Low Blood Sugar Frequently - PR Newswire 11.28.12 | 08:11 am
- Novo Nordisk To Award $100,000 To Local Programs That Help People Living With Diabetes In Madison And Milwaukee As Part Of Educational Initiative - PR Newswire 09.19.12 | 09:09 am
- Former Miss America Nicole Johnson And NBA Hall-of-Famer Dominique Wilkins To Join Novo Nordisk Employees From Across U.S. For Diabetes Advocacy Day On Capitol Hill - PR Newswire 06.27.12 | 08:06 am
- Novo Nordisk To Award $80,000 To Local Programs That Help People Living With Diabetes In Detroit As Part Of Educational Initiative - PR Newswire 06.26.12 | 08:06 am
- Is There Sexual Intimacy After Menopause? Canadian Women Reveal Greater Need For Physician-Women Dialogue Regarding Vaginal Health - PR Newswire 06.26.12 | 06:06 am
- Novo Nordisk To Award $80,000 To Local Programs That Help People Living With Diabetes In San Francisco As Part Of Educational Initiative - PR Newswire 06.19.12 | 11:06 am
Partner Headlines for NVO
- Encouraging Data on Novartis' Gilenya - Analyst Blog - Zacks 06.14.13 | 10:06 pm
- This Under-The-Radar Diabetes Stock Has Significant Upside Potential - Seeking Alpha 06.11.13 | 09:06 am
- FDA Panel Positive on GSK's Avandia - Analyst Blog - Zacks 06.07.13 | 10:06 pm
- Why MannKind's Afrezza Will Succeed Where Pfizer Failed - Seeking Alpha 05.18.13 | 04:05 am
- Novo Nordisk Rapidly Raising Dividend - Investor's Business Daily 05.14.13 | 05:05 pm
- The Seeking Alpha Experiment: Portfolio Introduction And 2013 Quarter 1 Review - Seeking Alpha 04.12.13 | 08:04 pm
- Novo Nordisk A/S (NVO) Ex-Dividend Date Scheduled for March 21, 2013 - NASDAQ 03.19.13 | 01:03 pm
- Stock Averages Lose Ground As Tiny Cyprus Impacts - Investor's Business Daily 03.18.13 | 04:03 pm
- Stocks Keep Paring Losses; Meritage Homes At New High - Investor's Business Daily 03.18.13 | 03:03 pm
- Stocks Pare Losses In Afternoon; Novo Nordisk Sinks - Investor's Business Daily 03.18.13 | 01:03 pm
